Mycenax Biotech Overview
- Founded
- 2001

- Status
- Public
- Employees
- 194

- Stock Symbol
- 4726

- Share Price
- $1.26
- (As of Friday Closing)
Mycenax Biotech General Information
Description
Mycenax Biotech Inc is a Taiwan based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company's pipeline products include TuNEX(opinercept - lyophilizate), TuNEX(opinercept - solution), LusiNEX (tocilizumab), and Omalizumab.
Contact Information
- Research Zhunan Road
- 4th Floor, 50-7 Keyan Road
- Zhunan, Miaoli County 350-53
- Taiwan
Mycenax Biotech Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.26 | $1.24 | $0.41 - $2.42 | $161M | 128M | 1.07M |
Mycenax Biotech Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 193,627 | 88,865 | 79,461 | 75,886 |
Revenue | 20,667 | 12,648 | 7,008 | 10,452 |
EBITDA | 4,175 | (3,527) | (6,976) | (4,845) |
Net Income | 22 | (7,060) | (9,097) | (6,179) |
Total Assets | 55,134 | 47,011 | 36,580 | 44,228 |
Total Debt | 1,902 | 2,803 | 934 | 1,267 |
Mycenax Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Mycenax Biotech‘s full profile, request access.
Request a free trialMycenax Biotech Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Karen Wen | Founder & President |
Mycenax Biotech Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial